1.Economic studies of fertilization and embryo transfer.
Journal of Zhejiang University. Medical sciences 2019;48(5):580-585
fertilization and embryo transplantation (IVF-ET) technology is one of the main treatments for infertility. But IVF-ET is expensive and has not be covered by health insurance in most developing countries. Therefore, how to obtain the maximum success rate with the minimum cost is a common concern of clinicians and patients. At present, the economic studies on IVF-ET mainly focus on different ovulation stimulating drugs, different ovulation stimulating protocols, different transplantation methods and the number of transplants. But the process of IVF-ET is complex, the relevant methods of economic study are diverse, and there are no unified standard for outcome indicators, so there is no unified conclusion for more economical and effective protocol by now. Therefore, to analyze the economic studies of IVF-ET, and to explore appropriate evaluation methods and cost-effective protocols will be helpful for reasonable allocation of medical resources and guidance of clinical selection. It would provide policy reference to include the costs of IVF-ET treatment in health insurance in the future.
Economics, Medical
;
trends
;
Embryo Transfer
;
economics
;
statistics & numerical data
;
Female
;
Fertilization in Vitro
;
economics
;
statistics & numerical data
;
Humans
;
Infertility
;
economics
;
Insurance, Health
;
economics
;
statistics & numerical data
;
Ovulation Induction
2.Cumulative live birth rate after three ovarian stimulation IVF cycles for poor ovarian responders according to the bologna criteria.
Hui KE ; Xin CHEN ; Yu-dong LIU ; De-sheng YE ; Yu-xia HE ; Shi-ling CHEN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2013;33(3):418-422
This study explored the cumulative live birth rate after three ovarian stimulation in vitro fertilization (IVF) cycles for poor ovarian responders according to the Bologna criteria. In this retrospective cohort study, 479 poor ovarian responders according to the Bologna criteria in the first ovarian stimulation IVF cycle between July 2006 and January 2012 in our IVF centre were included. The cumulative live birth rate was calculated by optimistic and pessimistic methods. The cumulative live birth rate after three ovarian stimulation IVF cycles for poor ovarian responders according to the Bologna criteria was 12.7%-20.5%. The three-cycle cumulative live birth rate was 18.5%-24.5%, 13.2%-27.4% and 8.6%-14.9% for poor responders aged ≤35 years, 36-39 years and ≥40 years, respectively. In conclusion, poor responders according to the Bologna criteria can receive an acceptable cumulative live birth rate after three ovarian stimulation IVF cycles, especially poor responders aged <40 years.
Adult
;
China
;
epidemiology
;
Female
;
Fertilization in Vitro
;
statistics & numerical data
;
Humans
;
Infertility, Female
;
epidemiology
;
therapy
;
Live Birth
;
epidemiology
;
Middle Aged
;
Ovulation Induction
;
statistics & numerical data
;
Pregnancy
;
Treatment Outcome
;
Young Adult
3.PGT or ICSI? The impression of NGS-based PGT outcomes in nonmosaic Klinefelter syndrome.
Jing TONG ; Xiao-Ming ZHAO ; An-Ran WAN ; Ting ZHANG
Asian Journal of Andrology 2021;23(6):621-626
This retrospective study demonstrates the clinical outcomes of patients with nonmosaic Klinefelter's syndrome (KS) who underwent preimplantation genetic testing (PGT) with frozen-thawed testicular spermatozoa. Microdissection testicular sperm extraction (micro-TESE) was performed for sperm retrieval. Next-generation sequencing (NGS) was conducted for embryo analysis. A total of 18 couples aged ≤35 years were included, and 22 oocyte retrieval cycles were completed. Euploidy was detected in 29 of 45 (64.4%) embryos. Additionally, the numbers of aneuploid and mosaic embryos detected were 8 (17.8%) and 8 (17.8%), respectively, regardless of a lack of sex chromosome abnormalities. Finally, 13 couples with euploid embryos completed 14 frozen embryo transfer (FET) cycles. Ten couples had clinical pregnancies, and 6 of them had already delivered 5 healthy babies and 1 monozygotic twin. There were also 4 ongoing pregnancies and 2 biochemical pregnancies, but no early pregnancy loss was reported. Based on our results, we speculate that for KS patients, when sperm can be obtained by micro-TESE, the cryopreservation strategy makes the ovarian stimulation procedure more favorable for female partners. The paternal genetic risk of sex chromosome abnormalities in their offspring is extremely low in men with KS. In addition to PGT, the intracytoplasmic sperm injection (ICSI) procedure is comparably effective but more economical for young nonmosaic KS couples. ICSI should be offered as an option for such couples, but monitoring by prenatal genetic diagnosis is recommended.
Adult
;
Female
;
High-Throughput Nucleotide Sequencing/methods*
;
Humans
;
Klinefelter Syndrome/therapy*
;
Outcome Assessment, Health Care/statistics & numerical data*
;
Ovulation Induction/statistics & numerical data*
;
Pregnancy
;
Retrospective Studies
;
Sperm Injections, Intracytoplasmic/methods*
4.Minimal Stimulation Using Gonadotropin Combined with Clomiphene Citrate or Letrozole for Intrauterine Insemination.
Bo Hyon YUN ; Seung Joo CHON ; Joo Hyun PARK ; Seok Kyo SEO ; SiHyun CHO ; Young Sik CHOI ; Seok Hyun KIM ; Byung Seok LEE
Yonsei Medical Journal 2015;56(2):490-496
PURPOSE: To evaluate the efficacy of minimal stimulation using discretely administered gonadotropin combined with clomiphene citrate (CC) or letrozole (LTZ) for intrauterine insemination (IUI) cycles. MATERIALS AND METHODS: Total 257 IUI cycles from 158 infertile couples were assessed. A CC dose of 100 mg/day (n=126 cycles) or a LTZ dose of 5 mg/day (n=131 cycles) was administered on days 3-5 of the menstrual cycle for 5 days. Each group received human menopausal gonadotropin at a dose of 150 IU by two or three alternative day: CC combined with alternate-day regimen for 2 or 3 days (CC+300, n=37; CC+450, n=89) and LTZ combined with alternate-day regimen for 2 or 3 days (LTZ+300, n=36; LTZ+450, n=95). RESULTS: The clinical pregnancy rate was comparable between the CC and LTZ groups (18.3% vs. 13.0%, p=0.243). The clinical pregnancy rate also showed no significant difference among the 4 groups (21.6% vs. 16.9% vs. 11.1% vs. 12.6%, p=0.507). The multiple pregnancy rate was significantly higher in LTZ compared to CC group (37.5% vs. 8.7%, p=0.028) and in the LTZ+450 compared to CC+450 group (50% vs. 13.3%, p=0.038). Overall, there were 15 cases of ovarian hyperstimulation syndrome (OHSS), with the prevalence being significantly lower in the LTZ compared to CC group (1.5% vs. 10.3%, p=0.003). OHSS was more prevalent in the CC+450 compared to the LTZ+450 group (12.4% vs. 1.1%, p=0.002). CONCLUSION: Our findings suggest that minimal stimulation using two alternate-day gonadotropin with LTZ decreases the development of OHSS and multiple pregnancies, while maintaining comparable pregnancy rates in IUI cycles.
Adult
;
Aromatase Inhibitors/administration & dosage
;
Clomiphene/*administration & dosage/therapeutic use
;
Drug Administration Schedule
;
Drug Combinations
;
Female
;
Fertility Agents, Female/administration & dosage/therapeutic use
;
Fertilization in Vitro
;
Gonadotropins/*administration & dosage
;
Humans
;
Infertility, Female/*drug therapy
;
Insemination, Artificial/*statistics & numerical data
;
Nitriles/*administration & dosage
;
Ovulation Induction/methods/*statistics & numerical data
;
Pregnancy
;
Pregnancy Rate
;
Treatment Outcome
;
Triazoles/*administration & dosage
5.Minimal Stimulation Using Gonadotropin Combined with Clomiphene Citrate or Letrozole for Intrauterine Insemination.
Bo Hyon YUN ; Seung Joo CHON ; Joo Hyun PARK ; Seok Kyo SEO ; SiHyun CHO ; Young Sik CHOI ; Seok Hyun KIM ; Byung Seok LEE
Yonsei Medical Journal 2015;56(2):490-496
PURPOSE: To evaluate the efficacy of minimal stimulation using discretely administered gonadotropin combined with clomiphene citrate (CC) or letrozole (LTZ) for intrauterine insemination (IUI) cycles. MATERIALS AND METHODS: Total 257 IUI cycles from 158 infertile couples were assessed. A CC dose of 100 mg/day (n=126 cycles) or a LTZ dose of 5 mg/day (n=131 cycles) was administered on days 3-5 of the menstrual cycle for 5 days. Each group received human menopausal gonadotropin at a dose of 150 IU by two or three alternative day: CC combined with alternate-day regimen for 2 or 3 days (CC+300, n=37; CC+450, n=89) and LTZ combined with alternate-day regimen for 2 or 3 days (LTZ+300, n=36; LTZ+450, n=95). RESULTS: The clinical pregnancy rate was comparable between the CC and LTZ groups (18.3% vs. 13.0%, p=0.243). The clinical pregnancy rate also showed no significant difference among the 4 groups (21.6% vs. 16.9% vs. 11.1% vs. 12.6%, p=0.507). The multiple pregnancy rate was significantly higher in LTZ compared to CC group (37.5% vs. 8.7%, p=0.028) and in the LTZ+450 compared to CC+450 group (50% vs. 13.3%, p=0.038). Overall, there were 15 cases of ovarian hyperstimulation syndrome (OHSS), with the prevalence being significantly lower in the LTZ compared to CC group (1.5% vs. 10.3%, p=0.003). OHSS was more prevalent in the CC+450 compared to the LTZ+450 group (12.4% vs. 1.1%, p=0.002). CONCLUSION: Our findings suggest that minimal stimulation using two alternate-day gonadotropin with LTZ decreases the development of OHSS and multiple pregnancies, while maintaining comparable pregnancy rates in IUI cycles.
Adult
;
Aromatase Inhibitors/administration & dosage
;
Clomiphene/*administration & dosage/therapeutic use
;
Drug Administration Schedule
;
Drug Combinations
;
Female
;
Fertility Agents, Female/administration & dosage/therapeutic use
;
Fertilization in Vitro
;
Gonadotropins/*administration & dosage
;
Humans
;
Infertility, Female/*drug therapy
;
Insemination, Artificial/*statistics & numerical data
;
Nitriles/*administration & dosage
;
Ovulation Induction/methods/*statistics & numerical data
;
Pregnancy
;
Pregnancy Rate
;
Treatment Outcome
;
Triazoles/*administration & dosage